Wound Care Market Size, Share, Growth, Trends, and Global Industry Analysis: By Product (Advanced Wound Care Products, Surgical Wound Care Products, Traditional Wound Care Products), By Wound Type (Acute Wound, Chronic Wound), By End-Use (Hospitals & Clinics, Home Healthcare, Nursing Homes, Others) and Region Forecast 2020-2031

Wound Care Market size was valued at US$ 18,739.5 million in 2024 and is projected to reach US$ 26,722.0 million by 2031 at a CAGR of 5.2% from 2025-2031. The wound care market encompasses a wide range of medical products and therapies designed to support the healing of acute, chronic, and surgical wounds. It includes advanced wound dressings, traditional wound care products, negative pressure wound therapy systems, and biologics such as skin substitutes. These products are utilized in various healthcare settings including hospitals, clinics, and home care environments—to manage and accelerate the healing process, prevent infections, and improve patient outcomes. The market serves both consumer and clinical segments, addressing needs from minor injuries to complex conditions like diabetic foot ulcers, pressure ulcers, and post-operative wounds.

The wound care market has experienced steady growth due to rising incidences of chronic conditions such as diabetes, obesity, and cardiovascular diseases, which contribute to delayed wound healing. Additionally, the increasing elderly population, who are more prone to chronic wounds and surgical interventions, has significantly fueled demand. Technological advancements, such as the development of antimicrobial dressings, smart wound care devices, and regenerative therapies, have further enhanced treatment efficacy and broadened market applications. Moreover, government initiatives to improve healthcare infrastructure and the shift toward home-based wound care solutions are also driving expansion globally.

Facts & Figures

• In the U.S., over 2.5 million patients annually develop pressure ulcers, with 11% of nursing home residents affected (about 159,000 individuals in 2004) and 35% of those with stage?2+ ulcers receiving specialized wound care.

• Burns constitute a significant wound care challenge, with nearly 11 million new medically treated burn cases globally each year, causing over 180,000 deaths, particularly in low- and middle-income countries.

• Individuals with diabetes face a 19–34% lifetime risk of developing diabetic foot ulcers, with an estimated 9–26 million new cases globally each year, underscoring a major area of clinical need.

Key Developments

• In April 2025, AVITA Medical officially launched Cohealyx, a novel collagen-based dermal matrix designed to support cellular migration and revascularization, thereby prepping wound beds for advanced closure techniques. Its introduction complements AVITA’s RECELL System and PermeaDerm product suite, aiming for integrated care in full-thickness wounds and burns with observed wound bed integration in as little as seven days.
• In January 2023, MediWound shared new clinical data on EscharEx, an enzymatic debridement agent, at the Wound Healing Society and SAWC conferences. The presentations included findings on venous leg ulcers and diabetic foot ulcers from Phase III trials, highlighting its enhanced mechanism of action compared to traditional enzymatic treatments like Santyl.

Wound Care Market Segmentation

Based on the product

• Advanced Wound Care Products
• Surgical Wound Care Products
• Traditional Wound Care Products

In the wound care market, Advanced Wound Care Products are set to take the lead, thanks to the growing need for effective treatments for chronic and complex wounds. These products, especially foam dressings and hydrocolloids, are crafted to keep wounds moist, speed up healing, lower the chances of infection, and make patients more comfortable. A key factor driving their popularity is the increasing global prevalence of chronic wounds like diabetic foot ulcers, venous leg ulcers, and pressure sores. These conditions often require ongoing care, which makes traditional solutions inadequate for proper management. Advanced products are becoming the go-to choice in clinical settings because they help reduce how often dressings need to be changed and promote quicker healing. Plus, with continuous innovations like antimicrobial dressings and smart sensor-integrated products, clinical outcomes are improving and aligning with modern wound care practices. Consequently, hospitals and home healthcare providers are gradually moving away from conventional materials, boosting the demand for advanced wound care solutions.

Based on the data wound type

• Chronic Wounds
• Diabetic Foot Ulcers
• Pressure Ulcers
• Venous leg Ulcers
• Others
• Acute Wounds
• Surgical & traumatic wounds
• Burns

Based on the wound type, chronic wounds are anticipated to lead the wound care market, primarily driven by the rising prevalence of diabetes and aging populations worldwide. Chronic wounds—such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers—require prolonged and specialized care due to slow healing and high risk of infection. Among these, diabetic foot ulcers are the most significant contributors, especially in countries like the U.S., China, and India, where diabetes rates are surging. According to the International Diabetes Federation, over 537 million adults globally were living with diabetes in 2021, and a substantial proportion of them are at risk of developing foot ulcers. This growing health burden has intensified the demand for advanced wound care products and integrated management strategies. Additionally, healthcare systems are focusing on early intervention and prevention of chronic wound complications to reduce hospital readmissions and costs, further reinforcing chronic wounds as the dominant wound type in the global market.

Based on the end-use

• Hospitals & Clinics
• Home Healthcare
• Nursing Homes
• Others

Based on end-use, hospitals and clinics are anticipated to remain the leading segment in the wound care market, owing to their access to advanced infrastructure, skilled professionals, and a higher volume of complex wound cases. Hospitals typically manage acute wounds, post-surgical wounds, and severe chronic ulcers, which require specialized interventions such as negative pressure wound therapy (NPWT), surgical debridement, and infection control using advanced dressings. These procedures are often not feasible in lower-tier settings or at home, making hospitals the primary hub for critical wound management. Additionally, hospitals are more likely to adopt new wound care technologies, including digital wound assessment tools and smart dressings, due to stronger financial and research backing. The rising number of surgeries globally, along with the increasing burden of chronic diseases like diabetes and peripheral artery disease, also contributes to hospital-centric wound treatment demand. This consolidated expertise and resource access position hospitals and clinics at the forefront of market growth.